A detailed history of Aton Ra Partners transactions in Shockwave Medical, Inc. stock. As of the latest transaction made, Aton Ra Partners holds 4,022 shares of SWAV stock, worth $0. This represents 1.53% of its overall portfolio holdings.

Number of Shares
4,022
Previous 4,374 8.05%
Holding current value
$0
Previous $870,000 11.95%
% of portfolio
1.53%
Previous 1.83%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$160.99 - $215.69 $56,668 - $75,922
-352 Reduced 8.05%
4,022 $766,000
Q3 2023

Oct 25, 2023

SELL
$194.33 - $283.97 $24,874 - $36,348
-128 Reduced 2.84%
4,374 $870,000
Q2 2023

Jul 18, 2023

SELL
$223.05 - $302.68 $469,297 - $636,838
-2,104 Reduced 31.85%
4,502 $1.28 Million
Q1 2023

May 05, 2023

SELL
$175.41 - $217.92 $162,955 - $202,447
-929 Reduced 12.33%
6,606 $1.43 Million
Q4 2022

Feb 02, 2023

SELL
$204.38 - $296.82 $500,322 - $726,615
-2,448 Reduced 24.52%
7,535 $1.55 Million
Q3 2022

Nov 14, 2022

SELL
$195.21 - $310.53 $1.02 Million - $1.62 Million
-5,213 Reduced 34.31%
9,983 $2.78 Million
Q2 2022

Aug 15, 2022

SELL
$115.91 - $214.48 $1.19 Million - $2.2 Million
-10,266 Reduced 40.32%
15,196 $2.91 Million
Q1 2022

May 16, 2022

SELL
$127.96 - $207.36 $1.02 Million - $1.65 Million
-7,938 Reduced 23.77%
25,462 $5.28 Million
Q4 2021

Feb 14, 2022

SELL
$165.13 - $241.83 $200,632 - $293,823
-1,215 Reduced 3.51%
33,400 $5.96 Million
Q3 2021

Nov 15, 2021

BUY
$163.99 - $235.57 $533,295 - $766,073
3,252 Added 10.37%
34,615 $7.13 Million
Q2 2021

Aug 12, 2021

SELL
$131.45 - $201.49 $106,080 - $162,602
-807 Reduced 2.51%
31,363 $5.95 Million
Q1 2021

May 17, 2021

BUY
$92.73 - $142.05 $704,098 - $1.08 Million
7,593 Added 30.89%
32,170 $4.19 Million
Q4 2020

Feb 19, 2021

BUY
$67.44 - $103.72 $1.66 Million - $2.55 Million
24,577 New
24,577 $2.55 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Aton Ra Partners Portfolio

Follow Aton Ra Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

News

Stay updated on Aton Ra Partners with notifications on news.